日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT

一项针对接受HLA匹配无关供者造血干细胞移植患者的高剂量帕利夫明预防移植物抗宿主病(GVHD)的I/II期研究

Schulz, Eduard; Curtis, Lauren M; Holtzman, Noa G; Steinberg, Seth M; Wloka, Kaska; Ostojic, Alen; Mina, Alain; El Jurdi, Najla; Pirsl, Filip; Carpenter, Ashley; Golagha, Mahshid; Sirajuddin, Arlene; Heller, Theo; Shaffer, Brian C; Hakim, Frances T; Rubin, Jeffrey S; Gress, Ronald E; Pavletic, Steven Z

Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial

新型联合免疫疗法在HPV相关癌症患者中的临床疗效:一项非随机临床试验

Floudas, Charalampos S; Goswami, Meghali; Donahue, Renee N; Pastor, Danielle M; Redman, Jason M; Brownell, Isaac; Turkbey, Evrim B; Cordes, Lisa M; Steinberg, Seth M; Manu, Michell; Francis, Deneise C; Lamping, Elizabeth; Marté, Jennifer L; Kackley, Mary; Krauss, Elizabeth; Manukyan, Manuk; Jochems, Caroline; Schlom, Jeffrey; Gulley, James L; Strauss, Julius

Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling

针对晚期实体瘤,采用优化PARP抑制的肿瘤靶向拓扑异构酶I抑制剂递送:一项采用间隔给药方案的I期临床试验

Thomas, Anish; Takahashi, Nobuyuki; Oplustil O'Connor, Lenka; Redon, Christophe E; Mohindroo, Chirayu; Sciuto, Linda; Pongor, Lorinc; Schmidt, Keith T; Steinberg, Seth M; Aladjem, Mirit I; Figg, William Douglas; O'Connor, Mark J; Pommier, Yves

Hematopoietic cell transplantation for DOCK8 deficiency: Results from a prospective clinical trial

DOCK8 缺陷的造血干细胞移植:一项前瞻性临床试验的结果

Freeman, Alexandra F; Gonzalez, Corina E; Yates, Bonnie; Cole, Kristen; Little, Lauren; Flannelly, Erin; Steinberg, Seth M; Mo, George; Piette, Nicole; Hughes, Thomas E; Cuellar-Rodriguez, Jennifer; Gea-Banacloche, Juan; Heller, Theo; Hammoud, Dima A; Holland, Steve M; Kong, Heidi H; Young, Fernanda D; Jing, Huie; Kayaoglu, Basak; Su, Helen C; Pai, Sung-Yun; Hickstein, Dennis D; Shah, Nirali N

Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial

使用MEK抑制剂Selumetinib治疗1型神经纤维瘤病合并皮肤神经纤维瘤:一项非随机临床试验

Gross, Andrea M; Reid, Olivia H; Baldwin, Lauren A; Cannon, Ashley; Choo-Wosoba, Hyoyoung; Steinberg, Seth M; Lobbous, Mina; Wolters, Pamela L; Pichard, Dominique C; Tibery, Cecilia M; Dombi, Eva; Derdak, Joanne; Widemann, Brigitte C; Korf, Bruce R

Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma

原发性渗出性淋巴瘤预后评分(PEL-PS):HIV相关原发性渗出性淋巴瘤的国际验证预后评分

Lurain, Kathryn; Ramaswami, Ramya; Oksenhendler, Eric; Boutboul, David; Dalla Pria, Alessia; Ulrich, Lara; Shanmugasundaram, Krithika; Uldrick, Thomas S; Bower, Mark; Yarchoan, Robert; Gérard, Laurence; Steinberg, Seth M

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation

中等剂量移植后环磷酰胺用于清髓性HLA半相合骨髓移植

Hyder, Mustafa A; Dimitrova, Dimana; Sabina, Ruby; DeVries, Ashley; McCune, Jeannine S; McAdams, Meredith J; Flomerfelt, Francis A; McKeown, Christi; Sadler, Jennifer L; Chai, Amy; Hughes, Thomas E; Napier, Scott; Stokes, Anita; Sponaugle, Jennifer; Rechache, Kamil; Parta, Mark; Cuellar-Rodriguez, Jennifer; Figg, William D; Choo-Wosoba, Hyoyoung; Steinberg, Seth M; Kanakry, Jennifer A; Kanakry, Christopher G

The Road From NIH Training Grants for Surgeons: What is the Return on Investment?

NIH 外科医生培训补助金之路:投资回报率是多少?

Demblowski, Lindsay A; Larrain, Carolina; Coxen, Anna; Somervell, Helina; Choo-Wosoba, Hyoyoung; Steinberg, Seth M; Zeiger, Martha A

A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation.

一项针对伴或不伴有生殖系 BRCA 突变的转移性三阴性乳腺癌患者的 II 期试点研究,评估抗 PD-L1 药物 Durvalumab 和 PARP 抑制剂 Olaparib 的疗效。

Fujii Takeo, Cimino-Mathews Ashley, Lipkowitz Stanley, Lee Min-Jung, Nair Jayakumar, Solarz Britanny Brooke, Zimmer Alexandra, Redd Bernadette, Levy Elliot B, Rastogi Shraddha, Sato Nahoko, McCoy Ann, Steinberg Seth M, Lee Jung-Min

PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer

PRGN-2009 和 bintrafusp alfa 用于治疗晚期或转移性人乳头瘤病毒相关癌症患者

Floudas, Charalampos S; Goswami, Meghali; Donahue, Renee N; Strauss, Julius; Pastor, Danielle M; Redman, Jason M; Brownell, Isaac; Turkbey, Evrim B; Steinberg, Seth M; Cordes, Lisa M; Marté, Jennifer L; Khan, Maheen H; McMahon, Sheri; Lamping, Elizabeth; Manu, Michell; Manukyan, Manuk; Brough, Douglas E; Lankford, Amy; Jochems, Caroline; Schlom, Jeffrey; Gulley, James L